2.76 USD
↗ 0.06 (2.22%)AT CLOSE (11:59 AM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
2.76
↘ 0.01 (0.18%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
2.76
↘ 0.01 (0.18%)
Market: OPEN
Open?$2.74
High?$2.81
Low?$2.67
Prev. Close?$2.70
Volume?540.5K
Avg. Volume?751.3K
VWAP?$2.73
Rel. Volume?0.72x
Bid / Ask
Bid?$2.75 × 100
Ask?$2.78 × 100
Spread?$0.03
Midpoint?$2.76
Valuation & Ratios
Market Cap?195.0M
Shares Out?72.2M
Float?31.2M
Float %?51.4%
P/E Ratio?N/A
P/B Ratio?2.77
EPS?-$1.68
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.07Strong
Quick Ratio?4.07Strong
Cash Ratio?1.80Strong
Debt/Equity?0.44Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.77CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.4CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-172.3%WEAK▾
ROA?-98.8%WEAK▾
Cash Flow & Enterprise
FCF?$-115626000
Enterprise Value?$172.1M
Related Companies
Loading...
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
195.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190